Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gemcitabine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1229372C reveals a novel Reformatsky reaction for Gemcitabine intermediates, offering high selectivity and cost reduction in API manufacturing without chromatography.
Patent CN1989148A reveals a solid-state synthesis route for 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose, enabling scalable Gemcitabine production with superior purity.
Patent CN106478747B reveals high-yield sulfonated sugar synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Patent CN112979723B details a novel Schiff base purification strategy for Gemcitabine intermediates, ensuring superior purity and yield for pharmaceutical manufacturing.